REG - Cambridge Cognition - Directorate Change

Cambridge Cognition HoldingsAnnouncement

18/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241018:nRSR6785Ia&default-theme=true

RNS Number : 6785I  Cambridge Cognition Holdings PLC  18 October 2024

 

18 October 2024

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

 

Directorate change

 

Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets
digital solutions to assess brain health, announces that, further to the
announcement made on 12 September 2024 in which it stated that Dr Matthew
Stork had stepped down as Chief Executive Officer, the Company has now
received the formal resignation of Dr Stork as a Director of the Company and
all subsidiary entities of which he was a Director.

 

 

Enquiries:

 

 Cambridge Cognition Holdings plc                    c/o Hudson Sandler

 Dr Steven Powell, Chairman
 Panmure Liberum Limited (NOMAD and Joint Broker)    Tel: 020 7886 2968

 Freddy Crossley / Will Goode / Mark Rogers          (Corporate Finance)

 Rupert Dearden                                      (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)              Tel: 020 3903 7715

 David Poutney / James Serjeant

 Hudson Sandler (Financial PR and IR)                Tel: 020 7796 4133

 Dan de Belder / Hattie Dreyfus / Harry Griffiths    cog@hudsonsandler.com (mailto:cog@hudsonsandler.com)

Notes to Editors

 

About Cambridge Cognition

 

Cambridge Cognition is a technology company developing digital health products
to better understand, detect and treat conditions affecting brain health. The
Company's software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients early and
improve global efficiency in pharmaceutical and healthcare industries.

 

For further information visit: https://cambridgecognition.com/
(https://cambridgecognition.com/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGZMMGRNMGDZM